With significant worldwide growth in demand for microsampling technology, Neoteryx is opening new offices! We're expanding our European operations to better meet the needs of both new and existing customers for Mitra® devices and better share all the capabilities that come with them.
At-home blood sampling streamlines the process of therapeutic drug monitoring and creates comfort and emotional safety for children
At-home blood sampling provides convenience and cost savings to patients.
TORRANCE, California (August 16, 2018) – Neoteryx LLC, inventor of Volumetric Absorptive Microsampling (VAMS™) technology, has signed a research agreement with Cedars-Sinai in Los Angeles to initiate a study to find and measure new biomarkers in blood that potentially may predict treatment effectiveness and relapse in patients with inflammatory bowel disease (IBD) – a chronic and recurring immune response and inflammation of the gastrointestinal tract.